APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucagon Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Glucagon Drug Market Analysis and Forecast 2026-2032

2 January 2026192 pages

Choose your research edition.

Industry ResearchGlucagon Drug Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucagon Drug Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Glucagon Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucagon Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucagon Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Glucagon Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Glucagon Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Glucagon Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Glucagon Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Glucagon Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Glucagon Drug include Eli Lilly, Fresenius Kabi, Torrent Labs and Novo Nordisk, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Glucagon Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Glucagon Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Glucagon Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Glucagon Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Glucagon Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Glucagon Drug sales, projected growth trends, production technology, application and end-user industry.

Glucagon Drug Segment by Company

Eli Lilly

Fresenius Kabi

Torrent Labs

Novo Nordisk

Glucagon Drug Segment by Type

Inject Glucagon

Nasal Glucagon

Glucagon Drug Segment by Application

Cardiogenic Shock

General Use

Emergency Kits

Diagnostic & Motility

Others

Glucagon Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucagon Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Glucagon Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Glucagon Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glucagon Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Glucagon Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Inject Glucagon Major Manufacturers Table 3. Nasal Glucagon Major Manufacturers Table 4. Global Glucagon Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cardiogenic Shock Major Manufacturers Table 6. General Use Major Manufacturers Table 7. Emergency Kits Major Manufacturers Table 8. Diagnostic & Motility Major Manufacturers Table 9. Others Major Manufacturers Table 10. Glucagon Drug Industry Trends Table 11. Glucagon Drug Industry Drivers Table 12. Glucagon Drug Industry Opportunities and Challenges Table 13. Glucagon Drug Industry Restraints Table 14. Global Glucagon Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Glucagon Drug Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Glucagon Drug Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Glucagon Drug Revenue Market Share by Region (2021-2026) Table 18. Global Glucagon Drug Revenue Market Share by Region (2027-2032) Table 19. Global Glucagon Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Glucagon Drug Sales by Region (2021-2026) & (K Units) Table 21. Global Glucagon Drug Sales by Region (2027-2032) & (K Units) Table 22. Global Glucagon Drug Sales Market Share by Region (2021-2026) Table 23. Global Glucagon Drug Sales Market Share by Region (2027-2032) Table 24. Global Glucagon Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Glucagon Drug Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Glucagon Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Glucagon Drug Sales Market Share by Manufacturers (2021-2026) Table 28. Global Glucagon Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Glucagon Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Glucagon Drug Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Glucagon Drug Manufacturers, Product Type & Application Table 32. Global Glucagon Drug Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Glucagon Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Glucagon Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Glucagon Drug Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Glucagon Drug Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Glucagon Drug Revenue Market Share by Type (2021-2026) Table 39. Global Glucagon Drug Revenue Market Share by Type (2027-2032) Table 40. Global Glucagon Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Glucagon Drug Sales by Type (2021-2026) & (K Units) Table 42. Global Glucagon Drug Sales by Type (2027-2032) & (K Units) Table 43. Global Glucagon Drug Sales Market Share by Type (2021-2026) Table 44. Global Glucagon Drug Sales Market Share by Type (2027-2032) Table 45. Global Glucagon Drug Price by Type (2021-2026) & (US$/Unit) Table 46. Global Glucagon Drug Price by Type (2027-2032) & (US$/Unit) Table 47. Global Glucagon Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Glucagon Drug Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Glucagon Drug Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Glucagon Drug Revenue Market Share by Application (2021-2026) Table 51. Global Glucagon Drug Revenue Market Share by Application (2027-2032) Table 52. Global Glucagon Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Glucagon Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Glucagon Drug Sales by Application (2027-2032) & (K Units) Table 55. Global Glucagon Drug Sales Market Share by Application (2021-2026) Table 56. Global Glucagon Drug Sales Market Share by Application (2027-2032) Table 57. Global Glucagon Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Glucagon Drug Price by Application (2027-2032) & (US$/Unit) Table 59. Eli Lilly Company Information Table 60. Eli Lilly Business Overview Table 61. Eli Lilly Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Eli Lilly Glucagon Drug Product Portfolio Table 63. Eli Lilly Recent Development Table 64. Fresenius Kabi Company Information Table 65. Fresenius Kabi Business Overview Table 66. Fresenius Kabi Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Fresenius Kabi Glucagon Drug Product Portfolio Table 68. Fresenius Kabi Recent Development Table 69. Torrent Labs Company Information Table 70. Torrent Labs Business Overview Table 71. Torrent Labs Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Torrent Labs Glucagon Drug Product Portfolio Table 73. Torrent Labs Recent Development Table 74. Novo Nordisk Company Information Table 75. Novo Nordisk Business Overview Table 76. Novo Nordisk Glucagon Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Novo Nordisk Glucagon Drug Product Portfolio Table 78. Novo Nordisk Recent Development Table 79. North America Glucagon Drug Revenue by Type (2021-2026) & (US$ Million) Table 80. North America Glucagon Drug Revenue by Type (2027-2032) & (US$ Million) Table 81. North America Glucagon Drug Sales by Type (2021-2026) & (K Units) Table 82. North America Glucagon Drug Sales by Type (2027-2032) & (K Units) Table 83. North America Glucagon Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 84. North America Glucagon Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 85. North America Glucagon Drug Revenue by Application (2021-2026) & (US$ Million) Table 86. North America Glucagon Drug Revenue by Application (2027-2032) & (US$ Million) Table 87. North America Glucagon Drug Sales by Application (2021-2026) & (K Units) Table 88. North America Glucagon Drug Sales by Application (2027-2032) & (K Units) Table 89. North America Glucagon Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 90. North America Glucagon Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 91. North America Glucagon Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Glucagon Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 93. North America Glucagon Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 94. North America Glucagon Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 95. North America Glucagon Drug Sales by Country (2021-2026) & (K Units) Table 96. North America Glucagon Drug Sales by Country (2027-2032) & (K Units) Table 97. North America Glucagon Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 98. North America Glucagon Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 99. United States Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 100. Canada Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 101. Europe Glucagon Drug Revenue by Type (2021-2026) & (US$ Million) Table 102. Europe Glucagon Drug Revenue by Type (2027-2032) & (US$ Million) Table 103. Europe Glucagon Drug Sales by Type (2021-2026) & (K Units) Table 104. Europe Glucagon Drug Sales by Type (2027-2032) & (K Units) Table 105. Europe Glucagon Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 106. Europe Glucagon Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 107. Europe Glucagon Drug Revenue by Application (2021-2026) & (US$ Million) Table 108. Europe Glucagon Drug Revenue by Application (2027-2032) & (US$ Million) Table 109. Europe Glucagon Drug Sales by Application (2021-2026) & (K Units) Table 110. Europe Glucagon Drug Sales by Application (2027-2032) & (K Units) Table 111. Europe Glucagon Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 112. Europe Glucagon Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 113. Europe Glucagon Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe Glucagon Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. Europe Glucagon Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. Europe Glucagon Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 117. Europe Glucagon Drug Sales by Country (2021-2026) & (K Units) Table 118. Europe Glucagon Drug Sales by Country (2027-2032) & (K Units) Table 119. Europe Glucagon Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 120. Europe Glucagon Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 121. Germany Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 122. France Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 123. U.K. Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 124. Italy Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 125. Netherlands Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 126. Nordic Countries Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 127. China Glucagon Drug Revenue by Type (2021-2026) & (US$ Million) Table 128. China Glucagon Drug Revenue by Type (2027-2032) & (US$ Million) Table 129. China Glucagon Drug Sales by Type (2021-2026) & (K Units) Table 130. China Glucagon Drug Sales by Type (2027-2032) & (K Units) Table 131. China Glucagon Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 132. China Glucagon Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 133. China Glucagon Drug Revenue by Application (2021-2026) & (US$ Million) Table 134. China Glucagon Drug Revenue by Application (2027-2032) & (US$ Million) Table 135. China Glucagon Drug Sales by Application (2021-2026) & (K Units) Table 136. China Glucagon Drug Sales by Application (2027-2032) & (K Units) Table 137. China Glucagon Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 138. China Glucagon Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 139. Asia Glucagon Drug Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia Glucagon Drug Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia Glucagon Drug Sales by Type (2021-2026) & (K Units) Table 142. Asia Glucagon Drug Sales by Type (2027-2032) & (K Units) Table 143. Asia Glucagon Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 144. Asia Glucagon Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 145. Asia Glucagon Drug Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia Glucagon Drug Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Glucagon Drug Sales by Application (2021-2026) & (K Units) Table 148. Asia Glucagon Drug Sales by Application (2027-2032) & (K Units) Table 149. Asia Glucagon Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 150. Asia Glucagon Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 151. Asia Glucagon Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Glucagon Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Asia Glucagon Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Asia Glucagon Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 155. Asia Glucagon Drug Sales by Country (2021-2026) & (K Units) Table 156. Asia Glucagon Drug Sales by Country (2027-2032) & (K Units) Table 157. Asia Glucagon Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 158. Asia Glucagon Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 159. Japan Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 160. South Korea Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 161. India Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 162. Australia Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 163. China Taiwan Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 164. Southeast Asia Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 165. SAMEA Glucagon Drug Revenue by Type (2021-2026) & (US$ Million) Table 166. SAMEA Glucagon Drug Revenue by Type (2027-2032) & (US$ Million) Table 167. SAMEA Glucagon Drug Sales by Type (2021-2026) & (K Units) Table 168. SAMEA Glucagon Drug Sales by Type (2027-2032) & (K Units) Table 169. SAMEA Glucagon Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 170. SAMEA Glucagon Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 171. SAMEA Glucagon Drug Revenue by Application (2021-2026) & (US$ Million) Table 172. SAMEA Glucagon Drug Revenue by Application (2027-2032) & (US$ Million) Table 173. SAMEA Glucagon Drug Sales by Application (2021-2026) & (K Units) Table 174. SAMEA Glucagon Drug Sales by Application (2027-2032) & (K Units) Table 175. SAMEA Glucagon Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 176. SAMEA Glucagon Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 177. SAMEA Glucagon Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. SAMEA Glucagon Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. SAMEA Glucagon Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. SAMEA Glucagon Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 181. SAMEA Glucagon Drug Sales by Country (2021-2026) & (K Units) Table 182. SAMEA Glucagon Drug Sales by Country (2027-2032) & (K Units) Table 183. SAMEA Glucagon Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 184. SAMEA Glucagon Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Brazil Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 186. Argentina Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 187. Chile Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 188. Colombia Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 189. Peru Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 190. Saudi Arabia Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 191. Israel Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 192. UAE Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 193. Turkey Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 194. Iran Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 195. Egypt Glucagon Drug Revenue (2021-2032) & (US$ Million) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Glucagon Drug Distributors List Table 199. Glucagon Drug Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Glucagon Drug Image Figure 2. Global Glucagon Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucagon Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Inject Glucagon Image Figure 5. Nasal Glucagon Image Figure 6. Global Glucagon Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Glucagon Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cardiogenic Shock Image Figure 9. General Use Image Figure 10. Emergency Kits Image Figure 11. Diagnostic & Motility Image Figure 12. Others Image Figure 13. Global Glucagon Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Glucagon Drug Revenue (2021-2032) & (US$ Million) Figure 15. Global Glucagon Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Glucagon Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Glucagon Drug Revenue Market Share by Region (2021-2032) Figure 18. Global Glucagon Drug Sales (2021-2032) & (K Units) Figure 19. Global Glucagon Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Glucagon Drug Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Glucagon Drug Sales YoY (2021-2032) & (K Units) Figure 22. Europe Glucagon Drug Sales YoY (2021-2032) & (K Units) Figure 23. China Glucagon Drug Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Glucagon Drug Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Glucagon Drug Sales YoY (2021-2032) & (K Units) Figure 26. Global Glucagon Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Glucagon Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Glucagon Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Glucagon Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Glucagon Drug Revenue Market Share by Type (2021-2032) Figure 32. Global Glucagon Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Glucagon Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Glucagon Drug Sales Market Share by Type (2021-2032) Figure 35. Global Glucagon Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Glucagon Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Glucagon Drug Revenue Market Share by Application (2021-2032) Figure 38. Global Glucagon Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Glucagon Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Glucagon Drug Sales Market Share by Application (2021-2032) Figure 41. North America Glucagon Drug Revenue Share by Type (2021-2032) Figure 42. North America Glucagon Drug Sales Share by Type (2021-2032) Figure 43. North America Glucagon Drug Revenue Share by Application (2021-2032) Figure 44. North America Glucagon Drug Sales Share by Application (2021-2032) Figure 45. North America Glucagon Drug Revenue Share by Country (2021-2032) Figure 46. North America Glucagon Drug Sales Share by Country (2021-2032) Figure 47. Europe Glucagon Drug Revenue Share by Type (2021-2032) Figure 48. Europe Glucagon Drug Sales Share by Type (2021-2032) Figure 49. Europe Glucagon Drug Revenue Share by Application (2021-2032) Figure 50. Europe Glucagon Drug Sales Share by Application (2021-2032) Figure 51. Europe Glucagon Drug Revenue Share by Country (2021-2032) Figure 52. Europe Glucagon Drug Sales Share by Country (2021-2032) Figure 53. China Glucagon Drug Revenue Share by Type (2021-2032) Figure 54. China Glucagon Drug Sales Share by Type (2021-2032) Figure 55. China Glucagon Drug Revenue Share by Application (2021-2032) Figure 56. China Glucagon Drug Sales Share by Application (2021-2032) Figure 57. Asia Glucagon Drug Revenue Share by Type (2021-2032) Figure 58. Asia Glucagon Drug Sales Share by Type (2021-2032) Figure 59. Asia Glucagon Drug Revenue Share by Application (2021-2032) Figure 60. Asia Glucagon Drug Sales Share by Application (2021-2032) Figure 61. Asia Glucagon Drug Revenue Share by Country (2021-2032) Figure 62. Asia Glucagon Drug Sales Share by Country (2021-2032) Figure 63. SAMEA Glucagon Drug Revenue Share by Type (2021-2032) Figure 64. SAMEA Glucagon Drug Sales Share by Type (2021-2032) Figure 65. SAMEA Glucagon Drug Revenue Share by Application (2021-2032) Figure 66. SAMEA Glucagon Drug Sales Share by Application (2021-2032) Figure 67. SAMEA Glucagon Drug Revenue Share by Country (2021-2032) Figure 68. SAMEA Glucagon Drug Sales Share by Country (2021-2032) Figure 69. Glucagon Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Glucagon Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Inject Glucagon
  • Nasal Glucagon
Applications
  • Cardiogenic Shock
  • General Use
  • Emergency Kits
  • Diagnostic & Motility
  • Others
Companies covered
  • Eli Lilly
  • Fresenius Kabi
  • Torrent Labs
  • Novo Nordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Glucagon Drug Market by Type
  3. 1.2.1 Global Glucagon Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Inject Glucagon
  5. 1.2.3 Nasal Glucagon
  6. 1.3 Glucagon Drug Market by Application
  7. 1.3.1 Global Glucagon Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cardiogenic Shock
  9. 1.3.3 General Use
  10. 1.3.4 Emergency Kits
  11. 1.3.5 Diagnostic & Motility
  12. 1.3.6 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Glucagon Drug Market Dynamics
  1. 2.1 Glucagon Drug Industry Trends
  2. 2.2 Glucagon Drug Industry Drivers
  3. 2.3 Glucagon Drug Industry Opportunities and Challenges
  4. 2.4 Glucagon Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Glucagon Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Glucagon Drug Revenue by Region
  3. 3.2.1 Global Glucagon Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Glucagon Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Glucagon Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Glucagon Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Glucagon Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Glucagon Drug Sales by Region
  9. 3.4.1 Global Glucagon Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Glucagon Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Glucagon Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Glucagon Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Glucagon Drug Revenue by Manufacturers
  2. 4.1.1 Global Glucagon Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Glucagon Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Glucagon Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Glucagon Drug Sales by Manufacturers
  6. 4.2.1 Global Glucagon Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Glucagon Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Glucagon Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Glucagon Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Glucagon Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Glucagon Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Glucagon Drug Manufacturers, Product Type & Application
  13. 4.7 Global Glucagon Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Glucagon Drug Market CR5 and HHI
  16. 4.8.2 2025 Glucagon Drug Tier 1, Tier 2, and Tier 3
5 Glucagon Drug Market by Type
  1. 5.1 Global Glucagon Drug Revenue by Type
  2. 5.1.1 Global Glucagon Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Glucagon Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Glucagon Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Glucagon Drug Sales by Type
  6. 5.2.1 Global Glucagon Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Glucagon Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Glucagon Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Glucagon Drug Price by Type
6 Glucagon Drug Market by Application
  1. 6.1 Global Glucagon Drug Revenue by Application
  2. 6.1.1 Global Glucagon Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Glucagon Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Glucagon Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Glucagon Drug Sales by Application
  6. 6.2.1 Global Glucagon Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Glucagon Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Glucagon Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Glucagon Drug Price by Application
7 Company Profiles
  1. 7.1 Eli Lilly
  2. 7.1.1 Eli Lilly Company Information
  3. 7.1.2 Eli Lilly Business Overview
  4. 7.1.3 Eli Lilly Glucagon Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Eli Lilly Glucagon Drug Product Portfolio
  6. 7.1.5 Eli Lilly Recent Developments
  7. 7.2 Fresenius Kabi
  8. 7.2.1 Fresenius Kabi Company Information
  9. 7.2.2 Fresenius Kabi Business Overview
  10. 7.2.3 Fresenius Kabi Glucagon Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Fresenius Kabi Glucagon Drug Product Portfolio
  12. 7.2.5 Fresenius Kabi Recent Developments
  13. 7.3 Torrent Labs
  14. 7.3.1 Torrent Labs Company Information
  15. 7.3.2 Torrent Labs Business Overview
  16. 7.3.3 Torrent Labs Glucagon Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Torrent Labs Glucagon Drug Product Portfolio
  18. 7.3.5 Torrent Labs Recent Developments
  19. 7.4 Novo Nordisk
  20. 7.4.1 Novo Nordisk Company Information
  21. 7.4.2 Novo Nordisk Business Overview
  22. 7.4.3 Novo Nordisk Glucagon Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novo Nordisk Glucagon Drug Product Portfolio
  24. 7.4.5 Novo Nordisk Recent Developments
8 North America
  1. 8.1 North America Glucagon Drug Market Size by Type
  2. 8.1.1 North America Glucagon Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Glucagon Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Glucagon Drug Price by Type (2021-2032)
  5. 8.2 North America Glucagon Drug Market Size by Application
  6. 8.2.1 North America Glucagon Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Glucagon Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Glucagon Drug Price by Application (2021-2032)
  9. 8.3 North America Glucagon Drug Market Size by Country
  10. 8.3.1 North America Glucagon Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Glucagon Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Glucagon Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Glucagon Drug Market Size by Type
  2. 9.1.1 Europe Glucagon Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Glucagon Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Glucagon Drug Price by Type (2021-2032)
  5. 9.2 Europe Glucagon Drug Market Size by Application
  6. 9.2.1 Europe Glucagon Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Glucagon Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Glucagon Drug Price by Application (2021-2032)
  9. 9.3 Europe Glucagon Drug Market Size by Country
  10. 9.3.1 Europe Glucagon Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Glucagon Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Glucagon Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Glucagon Drug Market Size by Type
  2. 10.1.1 China Glucagon Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Glucagon Drug Sales by Type (2021-2032)
  4. 10.1.3 China Glucagon Drug Price by Type (2021-2032)
  5. 10.2 China Glucagon Drug Market Size by Application
  6. 10.2.1 China Glucagon Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Glucagon Drug Sales by Application (2021-2032)
  8. 10.2.3 China Glucagon Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Glucagon Drug Market Size by Type
  2. 11.1.1 Asia Glucagon Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Glucagon Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Glucagon Drug Price by Type (2021-2032)
  5. 11.2 Asia Glucagon Drug Market Size by Application
  6. 11.2.1 Asia Glucagon Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Glucagon Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Glucagon Drug Price by Application (2021-2032)
  9. 11.3 Asia Glucagon Drug Market Size by Country
  10. 11.3.1 Asia Glucagon Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Glucagon Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Glucagon Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Glucagon Drug Market Size by Type
  2. 12.1.1 SAMEA Glucagon Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Glucagon Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Glucagon Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Glucagon Drug Market Size by Application
  6. 12.2.1 SAMEA Glucagon Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Glucagon Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Glucagon Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Glucagon Drug Market Size by Country
  10. 12.3.1 SAMEA Glucagon Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Glucagon Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Glucagon Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Glucagon Drug Value Chain Analysis
  2. 13.1.1 Glucagon Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Glucagon Drug Production Mode & Process
  6. 13.2 Glucagon Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Glucagon Drug Distributors
  9. 13.2.3 Glucagon Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst